Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Tuberculosis

  Free Subscription


23.09.2019

4 Antimicrob Agents Chemother
1 Clin Infect Dis
3 Emerg Infect Dis
1 Eur Respir J
11 Int J Tuberc Lung Dis
2 J Clin Microbiol
3 Lancet
2 Lancet Glob Health
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. CARRIGY NB, Larsen SE, Reese V, Pecor T, et al
    Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00871.
    PubMed     Text format     Abstract available

  2. SOMMER R, Cole ST
    Monitoring Tuberculosis Drug Activity in Live Animals by Near-Infrared Fluorescence Imaging.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01280.
    PubMed     Text format     Abstract available

  3. HENDON-DUNN CL, Pertinez H, Marriott AAN, Hatch K, et al
    Re-growth of Mycobacterium tuberculosis populations exposed to antibiotic combinations is due to the presence of isoniazid and not bacterial growth rate.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00570.
    PubMed     Text format     Abstract available

  4. JO KW, Kim M, Kim YJ, Lee HK, et al
    Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDRplus assay: A prospective, multicenter, non-inferiority randomized trial in South Korea.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00980.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  5. WOLF A, Padayatchi N, Naidoo K, Master I, et al
    Spatial Temporal Clustering of Multi- and Extensively Drug Resistant Tuberculosis is Associated with HIV Status and Drug-susceptibility Pattern in KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2019 Sep 20. pii: 5572101. doi: 10.1093.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  6. VONNAHME LA, Haddad MB, Navin TR
    Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011-2012.
    Emerg Infect Dis. 2019;25:1949-1951.
    PubMed     Text format     Abstract available

  7. SAKHAEE F, Vaziri F, Bahramali G, Taremian K, et al
    Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran.
    Emerg Infect Dis. 2019;25:1984-1986.
    PubMed     Text format     Abstract available

  8. MURRAY KO, Castillo-Carandang NT, Mandalakas AM, Cruz AT, et al
    Prevalence of Tuberculosis in Children After Natural Disasters, Bohol, Philippines.
    Emerg Infect Dis. 2019;25:1884-1892.
    PubMed     Text format     Abstract available


    Eur Respir J

  9. SPRUIJT I, Tesfay Haile D, Suurmond J, van den Hof S, et al
    Latent tuberculosis screening and treatment among asylum seekers: a mixed methods study.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00861-2019.
    PubMed     Text format     Abstract available


    Int J Tuberc Lung Dis

  10. CHESOV D, Lange C, Heyckendorf J
    Molecular-based tuberculosis drug susceptibility testing: one size fits all?
    Int J Tuberc Lung Dis. 2019;23:879-880.
    PubMed     Text format    

  11. KRAKAUER EL, Dheda K, Kalsdorf B, Kuksa L, et al
    Palliative care and symptom relief for people affected by multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:881-890.
    PubMed     Text format     Abstract available

  12. MARX FM, Cohen T, Lombard C, Hesseling AC, et al
    Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa.
    Int J Tuberc Lung Dis. 2019;23:891-899.
    PubMed     Text format     Abstract available

  13. GURJAV U, Ankhbat M, Ganbaatar G, Batjarga K, et al
    Vitamin D deficiency is associated with tuberculosis infection among household contacts in Ulaanbaatar, Mongolia.
    Int J Tuberc Lung Dis. 2019;23:919-923.
    PubMed     Text format     Abstract available

  14. PARK S, Yang BR, Song HJ, Jang SH, et al
    Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
    Int J Tuberc Lung Dis. 2019;23:924-930.
    PubMed     Text format     Abstract available

  15. SUN Y, Gao L, Xia H, Yang Z, et al
    Accuracy of molecular diagnostic tests for drug-resistant tuberculosis detection in China: a systematic review.
    Int J Tuberc Lung Dis. 2019;23:931-942.
    PubMed     Text format     Abstract available

  16. TAHSEEN S, Ambreen A, Masood F, Qadir M, et al
    Primary drug resistance in extra-pulmonary tuberculosis: a hospital-based prospective study from Pakistan.
    Int J Tuberc Lung Dis. 2019;23:900-906.
    PubMed     Text format     Abstract available

  17. FRANKE MF, Rodriguez CA, Mitnick CD
    Causal inference in tuberculosis treatment studies: bias considerations and data needs.
    Int J Tuberc Lung Dis. 2019;23:960-961.
    PubMed     Text format    

  18. FURIN J, Frick M, McKenna L
    A human rights-based approach to tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2019;23:959.
    PubMed     Text format    

  19. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    In reply: A human rights-based approach to tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2019;23:959-960.
    PubMed     Text format    

  20. SONG HJ, Park H, Seo HJ
    Association between use of proton pump inhibitors and tuberculosis risk: a systematic review.
    Int J Tuberc Lung Dis. 2019;23:943-951.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  21. KWEON OJ, Lim YK, Kim HR, Kim TH, et al
    Evaluation of STANDARD E TB-Feron ELISA for the diagnosis of latent tuberculosis infection in healthcare workers.
    J Clin Microbiol. 2019 Sep 18. pii: JCM.01347-19. doi: 10.1128/JCM.01347.
    PubMed     Text format     Abstract available

  22. CAO Y, Parmar H, Simmons AM, Kale D, et al
    Automatic identification of individual rpoB gene mutations responsible for rifampin resistance in Mycobacterium tuberculosis using melting temperature signatures generated by the Xpert(R) MTB/RIF Ultra* assay.
    J Clin Microbiol. 2019 Sep 18. pii: JCM.00907-19. doi: 10.1128/JCM.00907.
    PubMed     Text format     Abstract available


    Lancet

  23. REUTER A, Hughes J, Furin J
    Challenges and controversies in childhood tuberculosis.
    Lancet. 2019;394:967-978.
    PubMed     Text format     Abstract available

  24. LANGE C, Dheda K, Chesov D, Mandalakas AM, et al
    Management of drug-resistant tuberculosis.
    Lancet. 2019;394:953-966.
    PubMed     Text format     Abstract available

  25. THE LANCET
    Tuberculosis needs accelerated and continued attention.
    Lancet. 2019;394:896.
    PubMed     Text format    


    Lancet Glob Health

  26. VESGA JF, Arinaminpathy N
    Modelling tuberculosis control priorities: more of the same will not do - Authors' reply.
    Lancet Glob Health. 2019;7:e1320.
    PubMed     Text format    

  27. WEJSE C, Ragonnet R, McBryde ES, Trauer JM, et al
    Modelling tuberculosis control priorities: more of the same will not do.
    Lancet Glob Health. 2019;7:e1319.
    PubMed     Text format    


    PLoS One


  28. Retraction: Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection.
    PLoS One. 2019;14:e0223028.
    PubMed     Text format    

  29. HAN SS, Lee SJ, Yim JJ, Song JH, et al
    Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
    PLoS One. 2019;14:e0222810.
    PubMed     Text format     Abstract available


  30. Correction: Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0222794.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: